Biodistribution and radiation dosimetry of the integrin marker 18F-RGD-K5 determined from whole-body PET/CT in monkeys and humans

M Doss, HC Kolb, JJ Zhang, MJ Bélanger… - Journal of Nuclear …, 2012 - Soc Nuclear Med
2-((2 S, 5 R, 8 S, 11 S)-5-benzyl-8-(4-((2 S, 3 R, 4 R, 5 R, 6 S)-6-((2-(4-(3-18F-fluoropropyl)-
1H-1, 2, 3-triazol-1-yl) acetamido) methyl)-3, 4, 5-trihydroxytetrahydro-2H-pyran-2 …

PET-based human dosimetry of the dimeric αvβ3 integrin ligand 68Ga-DOTA-E-[c (RGDfK)] 2, a potential tracer for imaging tumor angiogenesis

V López-Rodríguez, C Galindo-Sarco… - Journal of Nuclear …, 2016 - Soc Nuclear Med
Peptides containing the Arg-Gly-Asp (RGD) sequence have high affinity for αvβ3 integrin
receptors overexpressed in tumor cells. The objective of this research was to determine the …

PET-based human dosimetry of 18F-galacto-RGD, a new radiotracer for imaging αvβ3 expression

AJ Beer, R Haubner, I Wolf, M Goebel… - Journal of Nuclear …, 2006 - Soc Nuclear Med
18F-Galacto-RGD is a new tracer for PET imaging of αvβ3, a receptor involved in a variety of
pathologic processes including angiogenesis and metastasis. Our aim was to study the …

Blood Clearance Kinetics, Biodistribution, and Radiation Dosimetry of a Kit-Formulated Integrin αvβ3-Selective Radiotracer 99mTc-3PRGD2 in Non-Human …

B Jia, Z Liu, Z Zhu, J Shi, X Jin, H Zhao, F Li… - Molecular imaging and …, 2011 - Springer
Abstract Purpose 99m Tc-3PRGD 2 is a 99m Tc-labeled dimeric cyclic RGD peptide with
increased receptor binding affinity and improved kinetics for in vivo imaging of integrin α v β …

A microdose PET study of the safety, immunogenicity, biodistribution, and radiation dosimetry of 18F-FB-A20FMDV2 for imaging the integrin αvβ6

N Keat, J Kenny, K Chen, M Onega… - Journal of nuclear …, 2018 - Soc Nuclear Med
The αvβ6 integrin is involved in the pathogenesis of cancer and fibrosis. A radiolabeled 20-
amino-acid αvβ6-binding peptide, derived from the foot and mouth virus …

Pilot Pharmacokinetic and Dosimetric Studies of 18F-FPPRGD2: A PET Radiopharmaceutical Agent for Imaging αvβ3 Integrin Levels

ES Mittra, ML Goris, AH Iagaru, A Kardan, L Burton… - Radiology, 2011 - pubs.rsna.org
Purpose To assess the safety, biodistribution, and dosimetric properties of the positron
emission tomography (PET) radiopharmaceutical agent fluorine 18 (18F) FPPRGD2 (2 …

Quantitative PET imaging of tumor integrin αvβ3 expression with 18F-FRGD2

X Zhang, Z Xiong, Y Wu, W Cai, JR Tseng… - Journal of nuclear …, 2006 - Soc Nuclear Med
The development of noninvasive methods to visualize and quantify integrin αvβ3 expression
in vivo appears to be crucial for the success of antiangiogenic therapy based on integrin …

The biodistribution and radiation dosimetry of the Arg-Gly-Asp peptide 18F-AH111585 in healthy volunteers

BJ McParland, MP Miller, TJ Spinks… - Journal of Nuclear …, 2008 - Soc Nuclear Med
We report the safety, biodistribution, and internal radiation dosimetry of a new PET tracer,
18F-AH111585, a peptide with a high affinity for the αvβ3 integrin receptor involved in …

In vivo characterization of 4 68Ga-labeled multimeric RGD peptides to image αvβ3 integrin expression in 2 human tumor xenograft mouse models

D Lobeek, GM Franssen, MT Ma… - Journal of Nuclear …, 2018 - Soc Nuclear Med
αvβ3 integrins play an important role in angiogenesis and cell migration in cancer and are
highly expressed on the activated endothelial cells of newly formed blood vessels. Here, we …

[68Ga] NS3-RGD and [68Ga] Oxo-DO3A-RGD for imaging αvβ3 integrin expression: synthesis, evaluation, and comparison

PA Knetsch, M Petrik, C Rangger, G Seidel… - Nuclear medicine and …, 2013 - Elsevier
INTRODUCTION: 68Ga-labeled RGD peptides in combination with PET allow non-invasive
determination of αvβ3 integrin expression which is highly increased during tumor-induced …